Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024586084> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2024586084 endingPage "86" @default.
- W2024586084 startingPage "85" @default.
- W2024586084 abstract "We are writing to report a case of acute myopia in a 35-year-old white woman who received topiramate for headache prophylaxis. She has no prior history of myopia and a long-standing history of episodic headache adhering to the International Headache Society (IHS) criteria for migraine without aura. Approximately 8 months prior to her initial visit, she began developing visual aura associated with some headaches, and over the prior 3 to 4 months, her headache frequency had gradually increased. At the time of initial evaluation, she reported 30 headache days within the prior month, with 2 incapacitating days. Her neurologic examination was normal, and the impression was “transformed” migraine with and without aura. Oral topiramate 25 mg twice a day for 7 days was prescribed, with subsequent escalation to a target dose of 50 mg twice a day. Four days after increasing her dose to 50 mg twice daily she awoke with severe “blurry” vision and bilateral retrobulbar pain which was exacerbated by eye movements. Topiramate was stopped 2 days later. Neurologic evaluation 3 days following the onset of these symptoms was notable for Jaeger 1+ acuity, right eye and Jaeger 1 acuity, left eye with a near-card; she achieved Jaeger 1+ acuity, left eye with a pinhole. Examination was otherwise unremarkable. An ophthalmologic evaluation 1 day later was notable for distance visual acuity of 20 / 300, both eyes with correction by pinhole to 20 / 70. An Ansler grid, threshold visual field, and dilated examination were normal. Within 3 days of stopping topiramate, the patient reported improvement in her distance vision, and 6 days after stopping the drug, her vision was normal. To our knowledge, this is the third reported case of acute myopia induced by topiramate, and the first in a patient receiving topiramate for headache prophylaxis. Perhaps topiramate-related myopia results from the drug's inhibition of carbonic anhydrase activity." @default.
- W2024586084 created "2016-06-24" @default.
- W2024586084 creator A5042819749 @default.
- W2024586084 creator A5064107530 @default.
- W2024586084 creator A5084226301 @default.
- W2024586084 date "2002-01-01" @default.
- W2024586084 modified "2023-09-26" @default.
- W2024586084 title "Topiramate-Induced Myopia" @default.
- W2024586084 doi "https://doi.org/10.1046/j.1526-4610.2002.02019.x" @default.
- W2024586084 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12005284" @default.
- W2024586084 hasPublicationYear "2002" @default.
- W2024586084 type Work @default.
- W2024586084 sameAs 2024586084 @default.
- W2024586084 citedByCount "4" @default.
- W2024586084 countsByYear W20245860842012 @default.
- W2024586084 crossrefType "journal-article" @default.
- W2024586084 hasAuthorship W2024586084A5042819749 @default.
- W2024586084 hasAuthorship W2024586084A5064107530 @default.
- W2024586084 hasAuthorship W2024586084A5084226301 @default.
- W2024586084 hasConcept C118487528 @default.
- W2024586084 hasConcept C118552586 @default.
- W2024586084 hasConcept C141071460 @default.
- W2024586084 hasConcept C2777350023 @default.
- W2024586084 hasConcept C2777683783 @default.
- W2024586084 hasConcept C2778186239 @default.
- W2024586084 hasConcept C2778257484 @default.
- W2024586084 hasConcept C2778541695 @default.
- W2024586084 hasConcept C2780168130 @default.
- W2024586084 hasConcept C2780590625 @default.
- W2024586084 hasConcept C2780966972 @default.
- W2024586084 hasConcept C42219234 @default.
- W2024586084 hasConcept C71924100 @default.
- W2024586084 hasConceptScore W2024586084C118487528 @default.
- W2024586084 hasConceptScore W2024586084C118552586 @default.
- W2024586084 hasConceptScore W2024586084C141071460 @default.
- W2024586084 hasConceptScore W2024586084C2777350023 @default.
- W2024586084 hasConceptScore W2024586084C2777683783 @default.
- W2024586084 hasConceptScore W2024586084C2778186239 @default.
- W2024586084 hasConceptScore W2024586084C2778257484 @default.
- W2024586084 hasConceptScore W2024586084C2778541695 @default.
- W2024586084 hasConceptScore W2024586084C2780168130 @default.
- W2024586084 hasConceptScore W2024586084C2780590625 @default.
- W2024586084 hasConceptScore W2024586084C2780966972 @default.
- W2024586084 hasConceptScore W2024586084C42219234 @default.
- W2024586084 hasConceptScore W2024586084C71924100 @default.
- W2024586084 hasIssue "1" @default.
- W2024586084 hasLocation W20245860841 @default.
- W2024586084 hasLocation W20245860842 @default.
- W2024586084 hasOpenAccess W2024586084 @default.
- W2024586084 hasPrimaryLocation W20245860841 @default.
- W2024586084 hasRelatedWork W1607725489 @default.
- W2024586084 hasRelatedWork W2011735313 @default.
- W2024586084 hasRelatedWork W2029248794 @default.
- W2024586084 hasRelatedWork W2063701000 @default.
- W2024586084 hasRelatedWork W2077889939 @default.
- W2024586084 hasRelatedWork W2078253330 @default.
- W2024586084 hasRelatedWork W2099842030 @default.
- W2024586084 hasRelatedWork W2113717442 @default.
- W2024586084 hasRelatedWork W2168925435 @default.
- W2024586084 hasRelatedWork W2188191065 @default.
- W2024586084 hasVolume "42" @default.
- W2024586084 isParatext "false" @default.
- W2024586084 isRetracted "false" @default.
- W2024586084 magId "2024586084" @default.
- W2024586084 workType "article" @default.